Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,384 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04903236Recruiting
MRI and body test study during planned radiotherapy
This study uses MRI scans and blood and/or urine tests to measure changes in the body and imaging results during radiotherapy. It may help researchers understand how treatment affects the body and improve future planning.
ManchesterAges 18 years+ - NCT04905381Recruiting
Test a home language program to help toddlers prepare for school
This study looks at whether a home-based language program (called the LENA Start Program) can improve toddlers’ readiness for school. It focuses on families with toddlers around 16–30 months old in the Alief Independent School District area.
Houston, TexasAges 1.3 years–2.5 years - NCT04906928Recruiting
MRI study to better scan spinal inflammation
This study tests new MRI scan settings to see inflammatory changes in the spinal cord more clearly. It may help doctors choose better MRI images when first checking—or re-checking—spinal inflammation.
ParisAges 18 years+ - NCT04915248RecruitingPhase 2
Study of daratumumab, bortezomib, and dexamethasone for plasmablastic lymphoma
This trial tests how well a combination of daratumumab, bortezomib, and dexamethasone works in people with plasmablastic lymphoma that has returned or did not respond to prior treatment. It aims to shrink measurable tumors and improve outcomes, including for some people living with HIV.
AnconaAges 18 years+ - NCT04917601Recruiting
Digital coaching for childhood obesity with family app support
This study tests a digital support system (a mobile app) to help children and families with obesity treatment. You may be able to use the app alongside the usual care plan if you meet the study’s age, health, and communication requirements.
MessinaAges 4–17 - NCT04921137RecruitingPhase 4
Testing benefits and side effects of hormone therapy in older breast cancer patients
This study looks at the potential harms and benefits of hormone (endocrine) therapy in people age 70 and older with early-stage, hormone-receptor–positive breast cancer. It may help doctors choose which hormone treatment approach is safest and most helpful for older patients.
Edmonton, AlbertaAges 70 years+ - NCT04923126RecruitingPhase 1/Phase 2
Mirdametinib for children with low-grade brain tumors
This Phase 1/2 study tests mirdametinib, a targeted medicine, in children and young adults with low-grade glioma (a slower-growing brain tumor). It aims to find the best dose and see how well the treatment works, especially for tumors with certain “MAPK pathway” changes.
Memphis, TennesseeAges 2–24 - NCT04926558Recruiting
Study testing trainee-reported outcomes in surgery training
This trial is for surgical residents and tests a new way for trainees to report how surgery went. It may help improve how surgical results and experiences are measured during training.
Barcelona, CataloniaAges Any age - NCT04929223RecruitingPhase 1
Targeted drug study for metastatic colon or rectal cancer
This Phase 1 study tests targeted cancer treatments in people with metastatic colorectal cancer, using genetic “biomarker” results to match you to the right treatment group. It focuses first on safety, and also looks for early signs the treatment may work in specific tumor subgroups.
Birmingham, AlabamaAges 18 years+ - NCT04929821Recruiting
Study of a dissolvable stent for bile duct narrowing
This study is testing a new type of stent that eventually dissolves on its own. The stent is placed in a narrowed bile duct to open it up and let bile flow properly. This might help people with strictures caused by scarring, stones, past surgeries, or certain bile duct cancers.
Hong KongAges 18 years+ - NCT04965454RecruitingPhase 2
Testing immune treatment benefit based on beta-catenin activity in liver cancer
This Phase 2 trial studies whether a liver-cancer feature called beta-catenin activity can predict who benefits from immune checkpoint inhibitor treatment. If you may not be a good candidate for surgery or local therapies, the trial may help match the right patients to this type of immunotherapy.
Honolulu, HawaiiAges 18 years+ - NCT04765137RecruitingPhase 2
Atorvastatin to improve brain blood flow in mild memory decline
This Phase 2 study tests whether the cholesterol medicine atorvastatin can improve how well blood vessels in the brain respond in people with mild cognitive impairment (MCI). It may help brain circulation and possibly slow thinking and memory problems.
Baltimore, MarylandAges 60–95 - NCT07699601RecruitingPhase 2/Phase 3
Testing a pain tablet after orthopedic surgery
This trial tests an investigational tablet called HL-1186 for controlling pain after orthopedic surgery. It explores whether the drug can safely reduce moderate to severe pain when given after the procedure.
Changsha, HunanAges 18–75 - NCT07698951Recruiting
Testing a new device to close PFO after stroke
This trial tests a new device to close a PFO (a small hole in the heart) in people who have had a stroke caused by a blood clot passing through that hole. The goal is to see if the device can prevent another stroke.
BelgradeAges 18–65 - NCT07311876Recruiting
Robotic surgery for head and neck lymphedema
This trial tests a new robotic-assisted surgery to reconnect tiny lymph vessels in people with head and neck swelling. It may help reduce the swelling and improve daily life.
KielAges 22 years+ - NCT00028080Recruiting
Evaluation and treatment for active Lyme disease
This study evaluates and treats people who currently have active Lyme disease, as defined by CDC criteria. It aims to provide expert care and follow-up while studying the disease.
Bethesda, MarylandAges 2–99 - NCT07306182RecruitingPhase 2
Testing SGC001 for anterior wall heart attack
This study tests an investigational drug called SGC001 for people having a heart attack affecting the front wall of the heart. The goal is to see if adding this drug to the standard artery-opening procedure helps improve outcomes.
Shanghai, Shanghai MunicipalityAges 18–79 - NCT07699120Enrolling by invitationPhase 1
Testing BRC-002 safety in healthy volunteers
This trial checks how safe BRC-002 is in healthy people and how it affects the body with and without food. It helps researchers understand the right dose and any side effects.
Toronto, OntarioAges 18–55 - NCT07638384Recruiting
MRI Muscle Oxygen Study Using Your Arm
This study uses MRI (a large imaging machine) to measure how much oxygen your arm muscles are getting during and after exercise. Researchers want to understand muscle health and oxygen use, which could help treat muscle diseases in the future.
New York, New YorkAges 20–64 - NCT05887609RecruitingPhase 2
Maintenance treatment for FRalpha-positive ovarian or endometrial cancer
This Phase 2 trial tests a combination of two medicines (mirvetuximab soravtansine and olaparib) as ongoing “maintenance” treatment after your best response to prior platinum chemotherapy. It may help keep cancer from growing longer in certain women whose tumors strongly match a specific marker (FRalpha).
Irvine, CaliforniaAges 18–100 - NCT07243002Recruiting
Patient outcomes with ribociclib or abemaciclib for early breast cancer
This study looks at how women and men with stage II or III HR+ HER2- breast cancer do when they start treatment with ribociclib or abemaciclib (combined with hormone therapy) after surgery. Researchers want to understand real-world experiences and results.
LondonAges 18 years+ - NCT04996706Enrolling by invitation
Studying lymphoma prognosis and survivorship in newly diagnosed patients
This study collects health information from people recently diagnosed with lymphoma to learn more about how the disease progresses and how to improve long-term well-being. It does not test a new treatment but helps researchers better understand what affects survival and quality of life.
Scottsdale, ArizonaAges 18 years+ - NCT07611968Recruiting
Physician-Modified Stent Grafts for Aortic Aneurysms
This trial tests a custom-made stent graft (a tube that reinforces the aorta from inside) for patients with large aortic aneurysms who may be too sick for traditional open surgery. The goal is to prevent rupture and complications while avoiding major surgery.
Jacksonville, FloridaAges 50 years+ - NCT06480591Recruiting
Study of CALR gene changes in blood cancers
This study looks at cells from people with a specific gene change called CALR, found in some blood cancers (myeloproliferative neoplasms). It aims to better understand how the disease works. No new treatments are being tested, but you may help researchers learn more about your condition.
Charlotte, North CarolinaAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,384 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.